Growth Metrics

Gyre Therapeutics (GYRE) Shareholder's Equity Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.00%
Dec 31, 2025 13.66%
Sep 30, 2025 51.39%
Jun 30, 2025 17.86%
Mar 31, 2025 56.74%
Dec 31, 2024 18.28%
Sep 30, 2024 17.48%
Jun 30, 2024 3.11%
Mar 31, 2024 -5.17%
Dec 31, 2023 -43.19%
Sep 30, 2023 -3.20%
Jun 30, 2023 -10.75%
Mar 31, 2023 -7.44%
Dec 31, 2022 1.86%
Sep 30, 2022 -28.77%
Jun 30, 2022 -5.31%
Mar 31, 2022 -36.51%
Dec 31, 2021 -20.85%
Sep 30, 2021 -22.40%
Jun 30, 2021 -14.65%
Mar 31, 2021 -10.01%
Dec 31, 2020 35.21%
Sep 30, 2020 55.78%
Jun 30, 2020 53.13%
Mar 31, 2020 91.73%
Dec 31, 2019 62.01%
Sep 30, 2019 60.64%
Jun 30, 2019 58.28%
Mar 31, 2019 55.78%
Dec 31, 2018 56.28%
Sep 30, 2018 53.11%
Jun 30, 2018 11.23%
Mar 31, 2018 11.43%
Dec 31, 2017 31.64%
Sep 30, 2017 -39.60%
Jun 30, 2017 -36.23%
Mar 31, 2017 -51.87%
Dec 31, 2016 29.19%
Sep 30, 2016 -48.88%
Jun 30, 2016 -47.05%
Mar 31, 2016 -45.13%
Dec 31, 2015 32.70%
Sep 30, 2015 -42.51%
Jun 30, 2015 -20.27%
Mar 31, 2015 -16.72%
Dec 31, 2014 -37.99%
Sep 30, 2014 -14.71%
Jun 30, 2014 -14.78%
Dec 31, 2013 -46.15%